{"id":52698,"date":"2023-01-09T16:02:19","date_gmt":"2023-01-09T15:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/north-america-ai-in-cancer-diagnostics-market-report-2022-ability-to-make-diagnoses-without-professional-radiologists-boosts-sector-researchandmarkets-com\/"},"modified":"2023-01-09T16:02:19","modified_gmt":"2023-01-09T15:02:19","slug":"north-america-ai-in-cancer-diagnostics-market-report-2022-ability-to-make-diagnoses-without-professional-radiologists-boosts-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/north-america-ai-in-cancer-diagnostics-market-report-2022-ability-to-make-diagnoses-without-professional-radiologists-boosts-sector-researchandmarkets-com\/","title":{"rendered":"North America AI In Cancer Diagnostics Market Report 2022: Ability to Make Diagnoses Without Professional Radiologists Boosts Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “North America AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user (Hospital, Surgical Centers & Medical Institutes), By Component (Software Solutions, Hardware and Services), By Cancer Type, By Country and Growth Forecast, 2022 – 2028”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe North America AI In Cancer Diagnostics Market should witness market growth of 27.8% CAGR during the forecast period (2022-2028).\n<\/p>\n

\nThe complete and updated MRI-guided biopsies designed by the NCI scientists are now accessible in clinics and hospitals which don’t require the need of cancer-specific professionals due to this AI tool. The new AI-featured algorithms have overpassed the abilities of professional radiologists by allowing the forecast of patient reports utilizing MRI. However, advanced AI methods can be employed to discover the gene mutations from tumor pathology images rather than utilizing standard genomic sequencing.\n<\/p>\n

\nFor example, scientists at New York University backed by the NCI utilized the deep learning technique to discover pathology images of lung tumors received from the Cancer Genome Atlas. Deep learning techniques can also be utilized to distinguish and detect Adenocarcinoma and squamous cell carcinoma which are the most prevalent lung cancer subtypes along with the identification of the altered genes from the images.\n<\/p>\n

\nIn collaboration with the Department of Energy (DOE), the Cancer Moonshot is assisting two crucial efforts to utilize its supercomputing expertise and capacity for cancer research and development. Moreover, Artificial intelligence is utilized to analyze and explain characteristics of the targeted molecules such as nucleic or protein acids that are crucial for the evolution of cancer also AI helps to predict new medication for targeted molecules and assets evaluating the efficacy of the medication.\n<\/p>\n

\nCancer is one of the foremost causes of mortality in the United States. The early-stage diagnosis of cancer is still a complicated procedure in most healthcare facilities. Due to the growing government actions and growing recession along with the enhancement in the healthcare industry. There were 863,830 female cases and 888,905 male cases of new invasive cancer recorded in the United States in 2019. The incidence rate for all cancers combined was 439 per 100,000 people in the general population.\n<\/p>\n

\nThe US market dominated the North America AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $146.7 million by 2028. The Canada market is experiencing a CAGR of 30.7% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 29.6% during (2022-2028).\n<\/p>\n

\nScope of the Study<\/strong>\n<\/p>\n

\nBy End-user<\/strong>\n<\/p>\n